BPB-101 in Subjects With Metastatic or Locally Advanced Solid Tumors
Clinical trial NCT05869240 · UNKNOWN
Trial details
- NCT number
- NCT05869240
- Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-16
- Primary completion
- 2025-08-02
- Enrollment
- 388
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.